Common Stock, Shares, Outstanding of Ovid Therapeutics Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Ovid Therapeutics Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Ovid Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 71,151,981, a 0.2% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Ovid Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 71,151,981 +142,115 +0.2% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 71,109,514 +137,937 +0.19% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 71,109,514 +325,553 +0.46% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 71,009,866 +317,874 +0.45% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 71,009,866 +329,315 +0.47% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 70,971,577 +368,784 +0.52% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 70,783,961 +292,451 +0.42% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 70,691,992 +225,107 +0.32% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 70,680,551 +213,666 +0.3% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 70,602,793 +183,405 +0.26% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 70,491,510 +74,265 +0.1% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 70,466,885 +101,973 +0.14% 31 Dec 2022 10-K 08 Mar 2024 2023 FY
Q3 2022 70,466,885 +2,450,144 +3.6% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 70,419,388 +2,585,441 +3.8% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 70,417,245 +2,629,419 +3.9% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 70,364,912 +4,621,742 +7% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q3 2021 68,016,741 +4,581,519 +7.2% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 67,833,947 +10,751,847 +19% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 67,787,826 +13,033,761 +24% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 65,743,170 +11,032,848 +20% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 63,435,222 +25,968,788 +69% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 57,082,100 +18,389,082 +48% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 54,754,065 +16,061,047 +42% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 54,710,322 +30,056,208 +122% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 37,466,434 +12,812,320 +52% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 38,693,018 +14,061,046 +57% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 38,693,018 +14,075,039 +57% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 24,654,114 +47,858 +0.19% 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q3 2018 24,654,114 +52,178 +0.21% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 24,631,972 +30,036 +0.12% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 24,617,979 +14,779,389 +150% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 24,606,256 +14,767,666 +150% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 24,601,936 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 24,601,936 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 9,838,590 31 Mar 2017 10-Q 13 Jun 2017 2017 Q1
Q4 2016 9,838,590 31 Dec 2016 10-K 29 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.